Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
PROBIOTEC financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$22.8
2024-10-29
Market Capitalization
$92.5 M
2024-08-26
Revenue
$214 M
FY, 2023
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| AUD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|---|---|---|
| Revenue | 76.7M | 80.3M | 108.8M | 120.5M | 182.3M | 214.0M |
| Cost of goods sold | 43.9M | 50.1M | 70.1M | 73.6M | 112.8M | 138.4M |
| Gross profit | 33.5M | 30.6M | 39.0M | 46.9M | 72.3M | 76.3M |
| Gross profit margin, % | 43.7% | 38.1% | 35.9% | 38.9% | 39.7% | 35.6% |
| Operating expense total | 24.4M | 25.4M | 25.6M | 28.0M | 35.2M | 40.9M |
| Depreciation and amortization | 3.0M | 3.3M | 5.3M | 8.2M | 14.8M | 14.0M |
| EBITDA | 9.1M | 5.3M | 13.4M | 19.0M | 37.2M | 35.4M |
| EBITDA margin, % | 11.9% | 6.6% | 12.3% | 15.7% | 20.4% | 16.5% |
| EBIT | 6.1M | 16.0M | 8.6M | 10.8M | 22.4M | 21.3M |
| EBIT margin, % | 7.9% | 19.9% | 7.9% | 9.0% | 12.3% | 10.0% |
| Interest expense | 672.0K | 1.9M | 2.3M | 3.4M | 4.3M | 5.8M |
| Pre tax profit | 5.4M | 10.8M | 5.4M | 7.4M | 18.0M | 15.6M |
| Income tax expense | 1.9M | (553.0K) | 1.9M | 2.6M | 4.3M | 4.6M |
| Net Income | 3.6M | 11.3M | 3.5M | 4.8M | 13.7M | 11.0M |